Burning Rock Biotech (BNR) Total Non-Current Liabilities (2019 - 2026)

Burning Rock Biotech (BNR) has reported Total Non-Current Liabilities for 8 consecutive years, with $6.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Total Non-Current Liabilities rose 43.36% year-over-year to $6.0 million; the TTM figure through Mar 2026 stood at $6.0 million (up 43.36% YoY), while the FY2025 annual figure was $5.5 million, up 4.24% from the prior year.
• Total Non-Current Liabilities came in at $6.0 million for Q1 2026 at Burning Rock Biotech, up from $5.4 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $11.8 million in Q2 2024, with the low at $1.1 million in Q4 2023.
• Average Total Non-Current Liabilities over 5 years is $5.3 million, with a median of $4.3 million recorded in 2025.
• Across the five-year window, Total Non-Current Liabilities sank 87.88% in 2023 and soared 847.91% in 2024, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $2.5 million in 2022, then plunged by 54.02% to $1.1 million in 2023, then soared by 365.17% to $5.3 million in 2024, then grew by 1.15% to $5.4 million in 2025, then gained by 11.91% to $6.0 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $6.0 million, $5.4 million, and $3.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.